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The study is concerned with the conversion of apigenin-7-O-glucoside into apigenin 
in polyethylene glycol 6000 / dextran 20000 aqueous two-phase system by β-glucosidase. 
Apigenin was separated from apigenin-7-O-glucosideand β-glucosidase by their partition 
into opposite phases. In 14% PEG / 22.5% DEX aqueous two-phase system obtained yield 
of apigenin in top phase was 108%.
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INTRODUCTION
Apigenin, 5,7,4’-trihydroxyﬂavone, belongs to ﬂavones, one of the major subclasses 
of plant ﬂavonoids found in camomile. Apigenin exhibits  a distinct anxiolytic activity 
without evidencing sedation or muscle relaxant effects at doses similar to those used for 
classical benzodiazepines without the anticonvulsant action (1). It also shows inhibitory 
effect on TPA-mediated tumour promotion and antimutagenicity (2,3). Moreover, prelimi-
nary studies also showed the topical use of apigenin reduced UV-induced skin tumoro-
genesis (3).
Like the most ﬂavones, apigenin is usually found in plants bound to sugars as glyco-
sides or in ester form with tannin acids. The pharmacological activity of apigenin-gluco-
side form is much lower than that of aglycone – apigenin. The conversion of apigenin-
7-O-glucoside was possible by autofermentation (4) and by the action of β-glucosidase 
(4-7). When bioconversion is conducted, reuse of biocatalyst, either the whole cell or the 198
enzyme, is always beneﬁcial. Aqueous two-phase system (ATPS) opens the possibility 
for performing the extractive bioconversions, in which integration of bioconversion and 
product removal is achieved with the posibility of repeated use of the biocatalyst. Such 
systems have proven to be a convenient medium for bioconversion of pharmacologically 
active compounds (8, 9).
The aim of this study was to investigate the possibility of bioconversion of apigenin-
glucosides by β-glucosidase in the aqueous two-phase system composed of polyethylene 
glycol and dextran. Conditions concerning phase system composition, where highest pos-
sible separation of apigenin and apigenin-glucoside into opposite phases is achieved, were 
previously established in model systems.
EXPERIMENTAL
Plant material
Camomile ligulate ﬂower: tetraploid camomile produced by the Institute for Hops, 
Broomcorn and Medicinal Herbs, Bački Petrovac (1997).
Chemicals
Standard samples of apigenin used in the present work were purchased from Sigma-
Aldrich Chemie GmbH. Dextran 20 000 ( w M  20000) (DEX) from Pharmacia (Uppsala, 
Sweden) and polyethylene glycol 6000 ( w M  6000) (PEG) from Merck (Germany) were 
used. β-Glucosidase (~6 U/mg) from Fluka AG (Switzerland) was applied. All other 
chemicals were of analytical reagent grade.
Sample preparation
Autofermentation of Camomile ligulate ﬂowers: Camomile ligulate ﬂowers (10 g) 
were moistened with 0.1 mol/dm3 Na-acetate buffer pH 5.5 (50 cm3) and autofermented at 
37°C for 72 hours. After that, the sample was dried at 40°C and extracted by 70% ethanol 
(5 g of sample and 250 cm3 of solvent) using ultrasound (40 min). After ﬁltration, the dry 
extract was obtained by solvent evaporation under vacuum. The dry extract was dissolved 
in 2 cm3 70% ethanol (Extract A).
Camomile ligulate ﬂowers extract: Camomile ligulate ﬂowers (2 g) were extracted 
by 70% ethanol (100 cm3) using ultrasound (40 min). After ﬁltration, the dry extract was 
obtained by solvent evaporation under vacuum. The dry extract was dissolved in 2 cm3 
70% ethanol (Extract B).
Aqueous two-phase system preparation
Phase systems for model system experiments were prepared by weighting PEG and 
DEX masses and dissolving in acetate buffer (0.1 mol/dm3 Na-acetate buffer pH 5.5), and 
then extract A (0.1cm3) was added and mixed thoroughly (10). The total mass of the two-
phase system was 2 g. Model ATPS was left to equilibrated at room temperature for 12 
hours, then the upper phase was carefully collected by syringe. 199
Extractive bioconversion
The enzyme dissolved in acetate buffer  (3 mg β-glucosidase in 100 g  0.1 mol/dm3 
Na-acetate buffer pH 5.5) or phosphate buffer (3 mg β-glucosidase in 100 g 0.1 mol/dm3 
phosphate buffer pH 5.5) was added to the model ATP systems. The bioconversion was 
performed at 55°C for 24 hours with constant mixing. The two phases were allowed to 
separate before sampling, then the upper phase was carefully collected using syringe.
Phase sample preparation for TLC and HPLC
Samples of the top phases (0.4 cm3) were added to activated Amberlite and adjusted to 
a ﬁnal volume of 1 cm3 with acetate buffer, then vortexed for 15 minutes and centrifuged 
(3000 rpm) for 10 minutes. After that samples were extracted from Amberlite with 70% 
ethanol (2 cm3) and analyzed by TLC and HPLC methods. 
Qualitative and quantitative analyses
TLC: Glass plates (20 x 20 cm), coated with silica gel GF254 (Fluka AG, Switzerland) 
thickness 0.5 mm, were used. Previously prepared samples extracted from Amberlite with 
70% ethanol were then applied: 5 µL of each sample solution was spotted on the plate, 
and, simultaneously, 15 µL of each solution of dry extract of Camomile ligulate  ﬂowers 
and dry extract of autofermented Camomile ligulate ﬂowers in 70% ethanol (Extracts A 
and B) were spotted. Development was at room temperature (approximately 20°C) in a 
glass chamber. The mobile phase was benzol : ethylmethylketon : methanol (5.5 : 3 : 1.5; 
v/v/v). The elution time was about 60 min. Detection was under UV light (254 nm). After 
that, by spraying the plate with 96% sulphuric acid and heating, yellow spots of separated 
ﬂavonoids appeared in daylight.
HPLC: Agilent Technologies 1100 HPLC system equipped with a binary pump, UV-
Diode Array detector, autosampler, Chem station software was used. Chromatographic 
conditions were: temperature 25°C termostated, column Zorbax, SB-C18 (4.6 x 150 mm, 
5 µm), guard column Zorbax, SB-C18 (4.6 x 12.5 mm, 5 µm). Elution proﬁle was isocrat-
ic: acetonitrile/H2O (3/7, v/v) with addition of acetic acid (1% of total volume). Injection 
volume was 10 µl, ﬂow rate 1.0 cm3/min, and stop time 40 min. Detection and quantiﬁca-
tion were conducted at UV 340 nm. Peak purity and identity were checked by comparison 
of the UV spectra (DAD-detector) and co-chromatography (TLC, HPLC) with reference 
substance (apigenin and apigenin-7-O-β-glucoside) and literature data (6). Quantiﬁcation 
of apigenin and apigenin glycoside was performed by HPLC method using a single point 
calibration with apigenin as an external standard (6).
Partition parameters
The partition coefﬁcient of apigenin in the aqueous two-phase systems was deﬁned as 
 
B
T
C
C
K    [1]
where CT and CB are the concentrations of apigenin in top and bottom phase, respec-
tively.200
The yield in top phase was deﬁned as
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where:
 C T and Co are concentration of apigenin in the top phase and in the extract loaded to 
ATPS, respectively,
 V T and V o are volumes of the top phase and the extract loaded to ATPS, respectively. 
RESULTS AND DISCUSSION
Preliminary investigations in model aqueous two-phase system were conducted to 
ﬁnd out if apigenin and apigenin-7-O-β-glucoside show afﬁnity to the top and the bottom 
phase, respectively, i.e. if there is a possibility of their separation in ATPS. For that, parti-
tion experiments were performed in the systems with dextran 20 000 (DEX) and polyeth-
ylene glycol 6000 (PEG), whose concentrations varied in the range from 14 to 48% DEX 
and from 4 to 22.5% PEG (compositions are given in Table 1), and qualitative analysis of 
the top phases by TLC was carried out.
The observation of ﬂavonoids’ spots under UV light and after staining (data not 
shown) revealed the presence of apigenin and absence of apigenin-7-O-β-glucoside in 
the top phase, showing that their separation in DEX / PEG ATPS is possible. This opened 
next step of our investigation - selection of a system giving the highest possible partition 
parameters for apigenin. In order to ﬁnd out appropriate conditions, partition studies were 
conducted in ATPS with different polymer concentrations. The concentration of apigenin 
in the top phase was determined by HPLC. In order to determine partition coefﬁcient, 
concentration of apigenin in the bottom phase was calculated from mass balance.
Table 1. Effect of  ATPS composition on the partition coefﬁcient
and the top phase yield of  apigenin
ATPS PEG (%, w/w)/ DEX (%, w/w) VT/VB KY T (%)
A 4.0/ 14.5 0.67 0.161 10.00
B 7.5/ 15.5 1.67 0.027 4.31
C 14.5/ 32.5 1.50 0.154 18.76
D 22.5/ 14.0 3.75 0.060 18.37
E 8.0/ 48.0 0.64 2.940 65.00
F 11.5/ 40.0 0.87 0.390 25.35
The highest obtained partition coefﬁcient for apigenin (2.94) was achieved in the 
system E, whose composition was 8.0% PEG and 48.0% DEX, followed by the highest 
top phase yield 65% (Table 1). Although content of apigenin in top phase in systems E and 
F was much higher then in other systems, we decided not to use them for further experi-
ments because of their high density due to high polymer concentration, which can cause 201
technical problems (separation, mixing). Using the systems C and D resulted in almost 
equal yield of apigenin in top phase, but our choice was system D, because it contains 
higher percentage of PEG, which is used as an auxiliary ingredient in pharmaceutical 
industry.
The next step was the investigation of 14.0% PEG/ 22.5% DEX ATPS for extractive 
biotransformation of apigenin-7-O-β-glucoside extracted from Camomile ligulate ﬂowers 
into apigenin by commercial β-glucosidase. In order to increase values for partition coef-
ﬁcient, enzymatic hydrolysis was also performed in phosphate buffer. Yield of apigenin in 
the top phase was calculated considering amounts of both apigenin and apigenin-gluco-
side present in the extract, determined by HPLC.
The bioconversion of Camomile ligulate ﬂowers extract by β-glucosidase under these 
conditions was successful and it resulted in the top phase apigenin yield of 108% (Table 
2). At the ﬁrst sight surprising yield value over 100% can be explained by the hydrolysis of 
not only apigenin-7-O-β-glucoside, but also of other apigenin glucosides - apigenin-7-O-
β-monoacetyl-glucoside and apigenin-7-O-β-diacetylglucoside present in camomile (7). 
Results showed that  phase volume ratio increased but content of apigenin in the top phase 
decreased when phosphate buffer was used, which resulted in lower yield of apigenin in 
the top phase. In both systems, β-glucosidase was present only in the bottom phase, which 
opens the possibility of its recirculation.
Table 2. Concentration and top phase yield of apigenin after extractive bioconversion
by β-glycosidase in ATPS 
Enzymatic
Conversion
DEX/PEG
(%, w/w)
VT/VB CT (mg/ml) YT (%)
Acetate buffer 14.0 / 22.5 2.91 0.28 108
Phosphate buffer 14.0 / 22.5 3.03 0.17 65
CONCLUSION
PEG / DEX ATPS is a convenient medium for the extractive bioconversion of apigen-
in-7-O-β-glucoside contained in camomile ﬂower extract into apigenin. After this process, 
apigenin is separated in the top phase, and, on the other hand, apigenin-7-O-β-glucoside, 
as well as the used enzyme β-glucosidase, in bottom phase. This experiment opens a lot 
of possibilities such as production of apigenin from camomile ﬂower extract using ATPS, 
recirculation of the biocatalyst and obtaining the product containing apigenin and PEG, 
which  could be used in pharmaceutical industry for production of tablets and creams.
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БИОКОНВЕРЗИЈА АПИГЕНИН-7-О-β-ГЛУКОЗИДА
У ВОДЕНОМ ДВОФАЗНОМ СИСТЕМУ
Сања М. Илић, Сања Д. Ђаковић, Јелена Х. Цвејић,
Мирјана Г. Антов u Зоран П. Зековић
Испитивана је конверзија апигенин-7-O-β-глукозида у апигенин помоћу β-глу-
козидазе у воденом двофазном систему полиетилен гликол 6000 / декстран 20000. 
Апигенин је био раздвојен од апигенин-7-O-β-глукозида и β-глукозидазе расподелом 
у различите фазе система. У воденом двофазном систему 14% PEG / 22,5% DEX пос-
тигнут принос апигенина у горњој фази је био 108%.
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